C5Research Selects and Deploys ImageIQ’s Imaging-Enabled Cloud-based EDCIQ for Cardiovascular Drug Clinical Trials

June 04, 2015

CLEVELAND, OHIO – June 4, 2015 – ImageIQ, an innovative Imaging Software and Contract Research Organization for preclinical research and clinical trials, announced today that C5Research, a Cleveland Clinic-based academic research organization (ARO), has selected EDCIQ for use in their Atherosclerosis Imaging Core Lab to manage and analyze imaging exams for cardiovascular drug and medical device clinical trials. C5Research designs, implements and conducts clinical trials for the pharmaceutical, biotechnology, and medical device companies who are developing new and innovative therapies for treating a broad spectrum of cardiovascular disease.

ImageIQ rebranded C5Research’s custom-tailored version of EDCIQ to iCAS (“Integrated Cardiovascular Analysis System”).  Prior to the implementation of iCAS, C5Research was using several software systems to manage imaging data upload, image tracking, screening and analysis – all common challenges in an industry where “one-size-fits-all” clinical trial management software is the standard. Because of ImageIQ’s expertise in biomedical imaging, image analysis, clinical trial workflow and software development, ImageIQ was able to create a customized solution that was far more cost effective, operationally efficient and compliant with regulatory standards. 

C5 Research Screen Capture

ImageIQ customized its EDCIQ for C5Research for its cardiovascular drug trials. This figure demonstrates the embedded image analysis tools for intravascular ultrasound (IVUS). Shown here is a single IVUS image analysis event in from a series of 80 images wherein the Lumen and External Elastic Membrane (EEM) border segmentations are shown in yellow and Plaque Thicknesses (PT) in orange with their respective measurement values shown on the right.

EDCIQ supports ImageIQ clients in their regulatory compliance for clinical trial image and data collection, viewing, analysis, storage, management and communication. Following the exact workflow that was optimal for C5 Research, utilizing iCAS yielded these results:

  • Significantly reduced technologist and physician work time
  • Reduced workflow complexity
  • Enhanced speed and access to images and data
  • Improved their ability to communicate with clinical trial sites

ImageIQ will be demonstrating its EDCIQ technology at the DIA 2015 Annual Meeting in Washington, DC, June 14-18, Booth #1227. 

ImageIQ is a Cleveland Clinic Innovations company.

# #  #

About ImageIQ

ImageIQ is an Imaging Contract Research Organization (ICRO) that combines software engineering with biomedical and imaging expertise to provide quantitative visual analysis that enhances R&D and product efficacy/safety testing for research, medical device and pharmaceutical organizations. Incubated within Cleveland Clinic for the better part of a decade, ImageIQ provides customized image analytics and reporting, delivering objective quantitative evidence that speeds time to discovery and market entry, reduces internal overhead and improves grant proposal attractiveness and fundability. By advancing the speed of research, ImageIQ customers can extend their expertise and abilities and complete work quickly, allowing innovative staff members to focus on creative solutions to research. www.Image-IQ.com


About C5Research

C5Research is a team of over 100 experienced and dedicated clinical trial specialists within the Heart and Vascular Institute of Cleveland Clinic that bring scientific and clinical leadership in cardiovascular disease in combination with operational excellence to conduct Phase II-IV multicenter clinical trials. Since 1991, C5Research has leveraged the clinical expertise of over 500 physicians throughout the Cleveland Clinic providing academic leadership and coordination to numerous trials ranging in size from <100 to 24,000 patients. In total, over 2000 sites have participated and enrolled over 150,000 subjects in C5Research trials. C5Research have access to expertise in cardiovascular disease that is recognized worldwide, as evidenced by the Cleveland Clinic Heart and Vascular Institute being ranked the # 1 program for cardiac care in the US for more than 20 years by "U.S. News & World Report."


Other News

Other Events